La bourse ferme dans 5 h 50 min

Bayer Aktiengesellschaft (BAYRY)

Other OTC - Other OTC Prix différé. Devise en USD
Ajouter à la liste dynamique
7,76-0,04 (-0,51 %)
À la clôture : 04:00PM EST

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
https://www.bayer.com

Secteur(s)Healthcare
Secteur d’activitéDrug Manufacturers - General
Employés à temps plein100 873

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Wolfgang U. NicklCFO & Member of Management Board2,3MS.O.1969
Mr. Heiko W. J. SchipperMember of Management Board & President of the Consumer Health Division2,08MS.O.1969
Mr. Stefan OelrichHead of the Pharmaceuticals Division & Member of the Board of Management2,26MS.O.1968
Mr. Rodrigo SantosMember of Management Board & President of the Crop Science Division2,35MS.O.1973
Mr. William N. AndersonChairman of the Management Board & CEOS.O.S.O.1966
Ms. Heike PrinzChief Talent Officer, Labor Director & Member of Management BoardS.O.S.O.1965
Dr. Jost ReinhardHead of Investor RelationsS.O.S.O.1972
Mr. Michael PreussHead of Communications, Government Relations and Corporate BrandS.O.S.O.S.O.
Mr. Bernd-Peter BierHead of Group FinanceS.O.S.O.1967
Mr. Robert LaCazeExecutive VP & Head of the Oncology Strategic Business UnitS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases, as well as collaboration with Bicycle Therapeutics to develop bicyclic peptides. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Bayer Aktiengesellschaft en date du 1 février 2024 est 6. Les scores principaux sont Audit : 10; Société : 2; Droits des actionnaires : 1; Compensation : 7.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.